TMEM4 is Highly Expressed in Plasma Cell Neoplasms and Associated with B Lymphocyte Differentiation

Journal Title: Immunological Disorders and Immunotherapy - Year 2016, Vol 1, Issue 1

Abstract

Aiming to identify biomarkers for plasma cell neoplasms, we analyzed gene expression profile and proteomic characteristics of mouse models of plasmacytomas along with other types of B-cell neoplasms. We found that transmembrane protein 4 (Tmem4) was highly expressed in plasmacytomas in comparison with early-stage B-cell neoplasms. The serum levels of Tmem4 were also significantly greater in mice with plasmacytoma comparing to those with early-stage B-cell neoplasms (P <0.01). Mechanistically, increased Tmem4 expression in B cells led to increased levels of IL-10, a cytokine that promotes the growth of malignant plasma cells and participates in the terminal differentiation of B cells into plasma cells. In addition, over-expression of Tmem4 promoted B cell terminal differentiation as evidenced by the increase in expression of XBP1, CD38, and CD138. Furthermore, we found that TMEM4 was highly expressed in plasma cells of multiple myeloma patients. These findings suggested that Tmem4 plays an important role in plasma cell differentiation and has a potential to serve as a biomarker for plasma cell neoplasms.

Authors and Affiliations

Chen-Feng Qi, Shao Xiang, Guifang Ouyang, Xing-pei Hao, Min Sun Shin, Alexander L Kovalchuk, Peng Liang, Huabao Xiong, Herbert C Morse III, Zhengping Zhuang, Jeff X Zhou and Susan K Pierce

Keywords

Related Articles

Curcumol Targets Gls1 to Regulate Glutamine Metabolism and Induce Senescence of Hepatic Stellate Cells to Exert Anti-Hepatic Fibrosis Mechanism

Objective: Curcuma has long been used as a Chinese herbal medicine for the treatment of chronic liver disease, and curcumol is its main active ingredient. This study explores the molecular mechanism of curcumol regulatin...

Profile of Cytotoxic Tcd8 Cells in Different forms of Malaria in Children

Introduction: Our study focused on the value of TCD8 cytotoxicity in susceptibility to severe malaria in endemic areas. The global purpose of the work hereby was to evaluate adaptive cellular immunity during Plasmodium f...

Bilateral Choroidal Metastasis as Initial Presentation of Parotid Gland Adenoid Cystic Carcinoma

Choroidal metastasis rarely reveals a primary cancer. At this stage, they are associated with multiple metastases. Adenoid cystic carcinoma also known as cylindroma is very rare and constitutes 1% of major and minor sali...

Unique COVID/Anti-Spike Protein Immune Responses in Two Elderly Patients without COVID-19 Vaccination

Published reports continue to emerge regarding different health outcomes in patients immunized and not immunized against the SARS-CoV-2 antigen (i.e., spike protein) that were infected with the virus. Because of the vast...

Hypertensive Emergency in Adolescent with Systemic Lupus Erythematosus at Onset: A Case Report

The severity of Systemic lupus erythematosus (SLE) at onset represents the most important biomarker of disease outcome and of treatment response in paediatric patients. Kidney disease, chronic systemic inflammation and s...

Download PDF file
  • EP ID EP743467
  • DOI -
  • Views 18
  • Downloads 0

How To Cite

Chen-Feng Qi, Shao Xiang, Guifang Ouyang, Xing-pei Hao, Min Sun Shin, Alexander L Kovalchuk, Peng Liang, Huabao Xiong, Herbert C Morse III, Zhengping Zhuang, Jeff X Zhou and Susan K Pierce (2016). TMEM4 is Highly Expressed in Plasma Cell Neoplasms and Associated with B Lymphocyte Differentiation. Immunological Disorders and Immunotherapy, 1(1), -. https://europub.co.uk/articles/-A-743467